Literature DB >> 30877321

Initial immunosuppression and managing rejection.

Thomas Fuehner1,2,3, Christian Benden4, Jens Gottlieb5,6.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30877321     DOI： 10.1007/s00134-018-05515-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Modulation of immunological responses by aqueous extract of Datura stramonium L. seeds on cyclophosphamide-induced immunosuppression in Wistar rats.

Authors:  Parker Elijah Joshua; Junaidu Yahaya; Daniel Emmanuel Ekpo; Joyce Oloaigbe Ogidigo; Arome Solomon Odiba; Rita Onyekachukwu Asomadu; Samson Ayodeji Oka; Olasupo Stephen Adeniyi
Journal:  BMC Immunol       Date:  2022-10-19       Impact factor: 3.594

Review 2.  Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation.

Authors:  Madonna Rica Anggelia; Ren-Wen Huang; Hui-Yun Cheng; Chih-Hung Lin; Cheng-Hung Lin
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

3.  Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?

Authors:  Quentin Faucher; Manon Jardou; Clarisse Brossier; Nicolas Picard; Pierre Marquet; Roland Lawson
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

4.  Ex vivo anchored PD-L1 functionally prevent in vivo renal allograft rejection.

Authors:  Zihuan Luo; Tao Liao; Yannan Zhang; Haofeng Zheng; Qipeng Sun; Fei Han; Maolin Ma; Yongrong Ye; Qiquan Sun
Journal:  Bioeng Transl Med       Date:  2022-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.